APA (7th ed.) Citation

Logan, N., Wright, D., Brownlie, R. J., Salmond, R. J., Zamoyska, R., Teagle, A. R., . . . Kapoor, S. S. (2023). Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Logan, Nicola, David Wright, Rebecca J. Brownlie, Robert J. Salmond, Rose Zamoyska, Alexandra Rose Teagle, Patricia Castro-Sanchez, and Simran S. Kapoor. Deletion of the Protein Tyrosine Phosphatase PTPN22 for Adoptive T Cell Therapy Facilitates CTL Effector Function but Promotes T Cell Exhaustion. BMJ Publishing Group, 2023.

MLA (9th ed.) Citation

Logan, Nicola, et al. Deletion of the Protein Tyrosine Phosphatase PTPN22 for Adoptive T Cell Therapy Facilitates CTL Effector Function but Promotes T Cell Exhaustion. BMJ Publishing Group, 2023.